Cara Therapeutics (CARA) PT Lowered to $7 at H.C. Wainwright
Get Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
H.C. Wainwright analyst Oren Livnat lowered the price target on Cara Therapeutics (NASDAQ: CARA) to $7.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Gemini Space Station (GEMI) PT Lowered to $7 at Mizuho
- Kotak Downgrades LG Electronics India (LGEL:IN) to Reduce (3)
- Alcon Inc. (ALC:SW) (ALC) PT Raised to CHF73 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share